Significant milestones and seminal discoveries during 1674-1966, by individuals who have made crucial contributions toward progress in the diagnosis of hematologic neoplasms as we understand today are depicted chronologically. It is notable that the path to progress in the understanding of disease and neoplasms initially took centuries for significant discoveries (17^th-18^th centuries), and subsequently, many decades (19^th-20^th centuries) for a breakthrough or a change from the prevailing norm. 

Posterior circulation tandem occlusion is an area of neurosurgery that has not been heavily studied, particularly in regards to treatment modalities. These strokes occur more rarely than other forms of stroke and, frequently, conventional surgical intervention is no longer an option by the time patients present to the hospital. 

The evolving molecular landscape of Smoldering Multiple Myeloma (SMM) has underscored its complex nature and the urgent need for more refined diagnostic and treatment strategies. With an increased risk of progression to Multiple Myeloma (MM), it has become important to identify patients at the highest risk of progression for interception strategies. Risk evaluation has been a constantly moving target with rapidly changing approaches to classification being based predominantly based on imaging and biochemical data thus far.

In recent years, the incidence of endometrial cancer has continued to increase and tends to be younger. An increasing number of young patients wish to preserve reproductive function during treatment. Although progestin therapy has a high remission rate, some patients experience hormone resistance, recurrence, or even disease progression, making this traditional treatment unsuitable for everyone.